271 related articles for article (PubMed ID: 16289419)
1. Controlled release of paclitaxel from photocrosslinked chitosan hydrogels and its subsequent effect on subcutaneous tumor growth in mice.
Obara K; Ishihara M; Ozeki Y; Ishizuka T; Hayashi T; Nakamura S; Saito Y; Yura H; Matsui T; Hattori H; Takase B; Ishihara M; Kikuchi M; Maehara T
J Control Release; 2005 Dec; 110(1):79-89. PubMed ID: 16289419
[TBL] [Abstract][Full Text] [Related]
2. Controlled release of fibroblast growth factors and heparin from photocrosslinked chitosan hydrogels and subsequent effect on in vivo vascularization.
Ishihara M; Obara K; Ishizuka T; Fujita M; Sato M; Masuoka K; Saito Y; Yura H; Matsui T; Hattori H; Kikuchi M; Kurita A
J Biomed Mater Res A; 2003 Mar; 64(3):551-9. PubMed ID: 12579570
[TBL] [Abstract][Full Text] [Related]
3. Controlled releases of FGF-2 and paclitaxel from chitosan hydrogels and their subsequent effects on wound repair, angiogenesis, and tumor growth.
Ishihara M; Fujita M; Obara K; Hattori H; Nakamura S; Nambu M; Kiyosawa T; Kanatani Y; Takase B; Kikuchi M; Maehara T
Curr Drug Deliv; 2006 Oct; 3(4):351-8. PubMed ID: 17076636
[TBL] [Abstract][Full Text] [Related]
4. pH- and temperature-sensitive, injectable, biodegradable block copolymer hydrogels as carriers for paclitaxel.
Shim WS; Kim JH; Kim K; Kim YS; Park RW; Kim IS; Kwon IC; Lee DS
Int J Pharm; 2007 Feb; 331(1):11-8. PubMed ID: 17049773
[TBL] [Abstract][Full Text] [Related]
5. Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel.
Kim JH; Kim YS; Kim S; Park JH; Kim K; Choi K; Chung H; Jeong SY; Park RW; Kim IS; Kwon IC
J Control Release; 2006 Mar; 111(1-2):228-34. PubMed ID: 16458988
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic angiogenesis induced by controlled release of fibroblast growth factor-2 from injectable chitosan/non-anticoagulant heparin hydrogel in a rat hindlimb ischemia model.
Fujita M; Ishihara M; Shimizu M; Obara K; Nakamura S; Kanatani Y; Morimoto Y; Takase B; Matsui T; Kikuchi M; Maehara T
Wound Repair Regen; 2007; 15(1):58-65. PubMed ID: 17244320
[TBL] [Abstract][Full Text] [Related]
7. The interaction of chitosan with fibroblast growth factor-2 and its protection from inactivation.
Masuoka K; Ishihara M; Asazuma T; Hattori H; Matsui T; Takase B; Kanatani Y; Fujita M; Saito Y; Yura H; Fujikawa K; Nemoto K
Biomaterials; 2005 Jun; 26(16):3277-84. PubMed ID: 15603823
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo characterization of a novel biocompatible polymer-lipid implant system for the sustained delivery of paclitaxel.
Ho EA; Vassileva V; Allen C; Piquette-Miller M
J Control Release; 2005 May; 104(1):181-91. PubMed ID: 15866344
[TBL] [Abstract][Full Text] [Related]
9. Chitosan hydrogel as a drug delivery carrier to control angiogenesis.
Ishihara M; Obara K; Nakamura S; Fujita M; Masuoka K; Kanatani Y; Takase B; Hattori H; Morimoto Y; Ishihara M; Maehara T; Kikuchi M
J Artif Organs; 2006; 9(1):8-16. PubMed ID: 16614797
[TBL] [Abstract][Full Text] [Related]
10. Hydrotropic oligomer-conjugated glycol chitosan as a carrier of paclitaxel: synthesis, characterization, and in vivo biodistribution.
Saravanakumar G; Min KH; Min DS; Kim AY; Lee CM; Cho YW; Lee SC; Kim K; Jeong SY; Park K; Park JH; Kwon IC
J Control Release; 2009 Dec; 140(3):210-7. PubMed ID: 19560497
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of an intratumoral controlled release formulation of clusterin antisense oligonucleotide complexed with chitosan containing paclitaxel or docetaxel in prostate cancer xenograft models.
Springate CM; Jackson JK; Gleave ME; Burt HM
Cancer Chemother Pharmacol; 2005 Sep; 56(3):239-47. PubMed ID: 15864591
[TBL] [Abstract][Full Text] [Related]
12. Acceleration of wound healing in healing-impaired db/db mice with a photocrosslinkable chitosan hydrogel containing fibroblast growth factor-2.
Obara K; Ishihara M; Fujita M; Kanatani Y; Hattori H; Matsui T; Takase B; Ozeki Y; Nakamura S; Ishizuka T; Tominaga S; Hiroi S; Kawai T; Maehara T
Wound Repair Regen; 2005; 13(4):390-7. PubMed ID: 16008728
[TBL] [Abstract][Full Text] [Related]
13. Controlled release of fibroblast growth factor-2 from an injectable 6-O-desulfated heparin hydrogel and subsequent effect on in vivo vascularization.
Nakamura S; Ishihara M; Obara K; Masuoka K; Ishizuka T; Kanatani Y; Takase B; Matsui T; Hattori H; Sato T; Kariya Y; Maehara T
J Biomed Mater Res A; 2006 Aug; 78(2):364-71. PubMed ID: 16673389
[TBL] [Abstract][Full Text] [Related]
14. Effect of controlled release of fibroblast growth factor-2 from chitosan/fucoidan micro complex-hydrogel on in vitro and in vivo vascularization.
Nakamura S; Nambu M; Ishizuka T; Hattori H; Kanatani Y; Takase B; Kishimoto S; Amano Y; Aoki H; Kiyosawa T; Ishihara M; Maehara T
J Biomed Mater Res A; 2008 Jun; 85(3):619-27. PubMed ID: 17806115
[TBL] [Abstract][Full Text] [Related]
15. Injectable chitosan hydrogels for localised cancer therapy.
Ta HT; Dass CR; Dunstan DE
J Control Release; 2008 Mar; 126(3):205-16. PubMed ID: 18258328
[TBL] [Abstract][Full Text] [Related]
16. Biodegradable nanoparticles based on linoleic acid and poly(beta-malic acid) double grafted chitosan derivatives as carriers of anticancer drugs.
Zhao Z; He M; Yin L; Bao J; Shi L; Wang B; Tang C; Yin C
Biomacromolecules; 2009 Mar; 10(3):565-72. PubMed ID: 19175304
[TBL] [Abstract][Full Text] [Related]
17. Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration.
Lv PP; Wei W; Yue H; Yang TY; Wang LY; Ma GH
Biomacromolecules; 2011 Dec; 12(12):4230-9. PubMed ID: 22044456
[TBL] [Abstract][Full Text] [Related]
18. [Preparation of functional chitosan thermosensitive hydrogel for slow release both rhBMP-2 and chlorhexidine].
Ma ZW; Wang R; Wu ZF; Chen D; Zhang BL; He W; Wang XJ; Liu Q; Xu J; Zhu H
Sheng Wu Gong Cheng Xue Bao; 2007 Nov; 23(6):1049-54. PubMed ID: 18257235
[TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro anti-cancer activity of thermo-sensitive and photo-crosslinkable doxorubicin hydrogels composed of chitosan-doxorubicin conjugates.
Cho YI; Park S; Jeong SY; Yoo HS
Eur J Pharm Biopharm; 2009 Sep; 73(1):59-65. PubMed ID: 19409990
[TBL] [Abstract][Full Text] [Related]
20. The effect of chitosan hydrogel containing DMEM/F12 medium on full-thickness skin defects after deep dermal burn.
Kiyozumi T; Kanatani Y; Ishihara M; Saitoh D; Shimizu J; Yura H; Suzuki S; Okada Y; Kikuchi M
Burns; 2007 Aug; 33(5):642-8. PubMed ID: 17475411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
